NEW YORK (GenomeWeb News) — Invitrogen and Viropro have signed an R&D agreement to integrate protein-production techniques and cell-development technology, Viropro said today.
Viropro, based in Montreal, also said the deal allows the company the opportunity to out-license the combined technology and make intellectual property deals with biotech companies looking to integrate the IP into their own research and production processes.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

360Dx reports that the US Centers for Medicare & Medicaid Services would cover next-generation sequencing-based cancer panel tests.

The Washington Post reports that a meteorologist is being considered as presidential science and technology advisor.

Researchers have developed a PCR-based assay to gauge whether manatees are present in waters.

In PNAS this week: precision medicine strategy to screen for disease risk, genome evolution in Haemophilus influenzae, and more.